Financial results - BICON PHARMA SRL

Financial Summary - Bicon Pharma Srl
Unique identification code: 36660199
Registration number: J2016004216231
Nace: 4773
Sales - Ron
461.296
Net Profit - Ron
-8.108
Employees
4
Open Account
Company Bicon Pharma Srl with Fiscal Code 36660199 recorded a turnover of 2024 of 461.296, with a net profit of -8.108 and having an average number of employees of 4. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Bicon Pharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - 0 143.620 283.041 311.692 322.804 358.963 398.054 412.322 461.296
Total Income - EUR - 0 143.621 283.044 311.707 322.807 373.251 398.086 412.324 461.303
Total Expenses - EUR - 3.379 143.389 260.411 296.894 318.009 350.320 395.299 412.575 468.907
Gross Profit/Loss - EUR - -3.379 232 22.634 14.813 4.798 22.931 2.787 -251 -7.604
Net Profit/Loss - EUR - -3.379 -1.205 19.799 11.692 1.798 19.469 -601 -4.168 -8.108
Employees - 1 4 4 4 4 3 4 4 4
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 12.5%, from 412.322 euro in the year 2023, to 461.296 euro in 2024.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Bicon Pharma Srl

Rating financiar

Financial Rating -
BICON PHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Bicon Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Bicon Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Bicon Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Bicon Pharma Srl - CUI 36660199

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - 2.629 1.903 1.203 27.295 20.645 15.205 9.379 4.331 371
Current Assets - 1.095 36.291 55.497 59.153 55.781 60.237 68.272 67.827 75.640
Inventories - 1.003 26.872 33.544 40.867 41.018 45.200 49.668 43.795 48.777
Receivables - 0 5.765 13.094 9.886 9.780 11.190 12.790 12.242 13.511
Cash - 92 3.654 8.858 8.399 4.983 3.847 5.813 11.790 13.352
Shareholders Funds - -3.335 -4.483 15.398 26.792 22.935 36.362 29.748 23.292 6.422
Social Capital - 45 44 43 42 41 40 41 40 40
Debts - 7.060 42.677 41.302 59.655 53.491 39.080 47.908 48.866 69.640
Income in Advance - 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 75.640 euro in 2024 which includes Inventories of 48.777 euro, Receivables of 13.511 euro and cash availability of 13.352 euro.
The company's Equity was valued at 6.422 euro, while total Liabilities amounted to 69.640 euro. Equity decreased by -16.740 euro, from 23.292 euro in 2023, to 6.422 in 2024.

Risk Reports Prices

Reviews - Bicon Pharma Srl

Comments - Bicon Pharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.